Literature DB >> 23884211

Alterations in vascular function in primary aldosteronism: a cardiovascular magnetic resonance imaging study.

P B Mark1, S Boyle1, L U Zimmerli2, E P McQuarrie1, C Delles1, E M Freel1.   

Abstract

Excess aldosterone is associated with increased cardiovascular risk. Aldosterone has a permissive effect on vascular fibrosis. Cardiovascular magnetic resonance imaging (CMR) allows study of vascular function by measuring aortic distensibility. We compared aortic distensibility in primary aldosteronism (PA), essential hypertension (EH) and normal controls and explored the relationship between aortic distensibility and pulse wave velocity (PWV). We studied PA (n=14) and EH (n=33) subjects and age-matched healthy controls (n=17) with CMR, including measurement of aortic distensibility, and measured PWV using applanation tonometry. At recruitment, PA and EH patients had similar blood pressure and left ventricular mass. Subjects with PA had significantly lower aortic distensibility and higher PWV compared with EH and healthy controls. These changes were independent of other factors associated with reduced aortic distensibility, including ageing. There was a significant relationship between increasing aortic stiffness and age in keeping with physical and vascular ageing. As expected, aortic distensibility and PWV were closely correlated. These results demonstrate that PA patients display increased arterial stiffness compared with EH, independent of vascular ageing. The implication is that aldosterone invokes functional impairment of arterial function. The long-term implications of arterial stiffening in aldosterone excess require further study.

Entities:  

Mesh:

Year:  2013        PMID: 23884211     DOI: 10.1038/jhh.2013.70

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  35 in total

1.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  Expert consensus document on arterial stiffness: methodological issues and clinical applications.

Authors:  Stephane Laurent; John Cockcroft; Luc Van Bortel; Pierre Boutouyrie; Cristina Giannattasio; Daniel Hayoz; Bruno Pannier; Charalambos Vlachopoulos; Ian Wilkinson; Harry Struijker-Boudier
Journal:  Eur Heart J       Date:  2006-09-25       Impact factor: 29.983

3.  Adrenalectomy improves arterial stiffness in primary aldosteronism.

Authors:  Branislav Strauch; Ondrej Petrák; Tomás Zelinka; Dan Wichterle; Robert Holaj; Mojmír Kasalický; Libor Safarík; Ján Rosa; Jirí Widimský
Journal:  Am J Hypertens       Date:  2008-07-24       Impact factor: 2.689

4.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

Authors:  Paul Milliez; Xavier Girerd; Pierre-François Plouin; Jacques Blacher; Michel E Safar; Jean-Jacques Mourad
Journal:  J Am Coll Cardiol       Date:  2005-04-19       Impact factor: 24.094

5.  Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.

Authors:  Yen-Hung Lin; Lian-Yu Lin; Aaron Chen; Xue-Ming Wu; Jen-Kuang Lee; Ta-Chen Su; Vin-Cent Wu; Shih-Chieh Chueh; Wei-Chou Lin; Men-Tzung Lo; Pa-Chun Wang; Yi-Lwun Ho; Kwan-Dun Wu
Journal:  Atherosclerosis       Date:  2011-12-08       Impact factor: 5.162

6.  Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study.

Authors:  Gary F Mitchell; Helen Parise; Emelia J Benjamin; Martin G Larson; Michelle J Keyes; Joseph A Vita; Ramachandran S Vasan; Daniel Levy
Journal:  Hypertension       Date:  2004-05-03       Impact factor: 10.190

7.  Cardiovascular outcomes in patients with primary aldosteronism after treatment.

Authors:  Cristiana Catena; GianLuca Colussi; Elisa Nadalini; Alessandra Chiuch; Sara Baroselli; Roberta Lapenna; Leonardo A Sechi
Journal:  Arch Intern Med       Date:  2008-01-14

8.  Increasing plasma free fatty acids in healthy subjects induces aortic distensibility changes seen in obesity.

Authors:  Oliver J Rider; Cameron J Holloway; Yaso Emmanuel; Edward Bloch; Kieran Clarke; Stefan Neubauer
Journal:  Circ Cardiovasc Imaging       Date:  2012-04-05       Impact factor: 7.792

9.  Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease.

Authors:  Patrick B Mark; Arthur Doyle; Kevin G Blyth; Rajan K Patel; Robin A P Weir; Tracey Steedman; John E Foster; Henry J Dargie; Alan G Jardine
Journal:  J Cardiovasc Magn Reson       Date:  2008-08-18       Impact factor: 5.364

10.  Uncomplicated obesity is associated with abnormal aortic function assessed by cardiovascular magnetic resonance.

Authors:  Monique R Robinson; Michaela Scheuermann-Freestone; Paul Leeson; Keith M Channon; Kieran Clarke; Stefan Neubauer; Frank Wiesmann
Journal:  J Cardiovasc Magn Reson       Date:  2008-02-13       Impact factor: 5.364

View more
  5 in total

Review 1.  Aldosterone excess and resistant hypertension: investigation and treatment.

Authors:  Michael Stowasser
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

2.  Long-term BP control and vascular health in patients with hyperaldosteronism treated with low-dose, amiloride-based therapy.

Authors:  Joseph L Izzo; Michael Hong; Tanveer Hussain; Peter J Osmond
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-06       Impact factor: 3.738

3.  Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism.

Authors:  Joseph L Izzo; Michael Hong; Tanveer Hussain; Peter J Osmond
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-07-26       Impact factor: 3.738

Review 4.  Treatment of Primary Aldosteronism and Organ Protection.

Authors:  Cristiana Catena; GianLuca Colussi; Leonardo A Sechi
Journal:  Int J Endocrinol       Date:  2015-05-17       Impact factor: 3.257

5.  Comparisons of microvascular and macrovascular changes in aldosteronism-related hypertension and essential hypertension.

Authors:  Monica Varano; Pierluigi Iacono; Massimiliano M Tedeschi; Claudio Letizia; Mario Curione; Claudio Savoriti; Erika Baiocco; Laura Zinnamosca; Cristiano Marinelli; Barbara Boccassini; Mariacristina Parravano
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.